🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525590-40-00
Authorised Phase I

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

2026-525590-40-00 · tracked via the Priya Life Science EU tracker
Sponsor
Viiv Healthcare UK Limited
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
18/05/2026
Enrollment target
9
Sites
Netherlands

Condition studied

human immunodeficiency virus (HIV)

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525590-40-00 on CTIS ↗ ← All trials in the EU